Photo by © Mark J. Rebilas - USA Today
USC Football

Athlon Sports: USC back in the postseason in 2019

June 4, 2019
1,144

Try Trojan Insider Premium content for $1.00!

Get excited, USC fans! OK, maybe not too excited unless you really enjoy trips back to a bowl game and a mediocre final national ranking.

According to Athlon Sports, Clay Helton is set to deliver the Trojans back into the postseason after missing a bowl game in 2018. The issue is that simply reaching postseason isn’t what USC fans want or what the program needs. 

The publication is high on quarterback JT Daniels, however, isn’t too bullish on his talent being able to take the Trojans higher than a 6-6 record. Why? USC’s schedule is brutal. The offensive line was labeled as the x-factor on that side of the ball.

The defensive line, what is considered to be the strength of the defense in 2019, is discussed generally while linebacker Palaie Gaoteote IV is noted as a promising individual on the next level of the defense.

Graham Harrell’s offense is enough to bring some excitement, but is 6-6 in his first year what USC fans want to see? Is reaching a bowl game really a success for this USC program? 

This is what was given as the “Final Analysis” for USC’s upcoming season.


Final Analysis

The Trojans should field a more competitive team in 2019. Then again, their schedule makes for a hard hill to climb. Oregon and Washington, the favorites in the North Division, return to the slate, and the nonconference games include road trips to BYU and Notre Dame. But no team in the Pac-12 is unassailable, and if USC can successfully regroup by fixing an offense that was at its least productive since 2001, then it can be a viable contender in the conference race.

National Ranking: 43

Discussion from...

Athlon Sports: USC back in the postseason in 2019

698 Views | 0 Replies | Last: 4 mo ago by Trojan Insider
There are not any replies to this post yet.
Page 1 of 1
 
×
Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.